Update AG Company Profile

12:19 EDT 23rd June 2018 | BioPortfolio



Seefeldstrasse 5a


Phone: 044 266 50 10
Fax: 044 266 50 11

News Articles [393 Associated News Articles listed on BioPortfolio]

Your Daily Pharma Scoop: Progenics Azerda Update, Atara Gets FDA Clearance For Phase 3 Trial, Avadel Provides Update

Gout Pipeline Highlights – 2017 Update –

DUBLIN–(BUSINESS WIRE)–The “Gout Pipeline Highlights – 2017 Update” drug pipelines has been added to’s offering. Gout Pipeline Highlights ...

2017 Atherosclerosis Pipeline Highlights Update –

DUBLIN–(BUSINESS WIRE)–The “Atherosclerosis Pipeline Highlights – 2017 Update” drug pipelines has been added to’s offering. Atherosclerosis P...

2017 Malaria Pipeline Highlights Update –

DUBLIN–(BUSINESS WIRE)–The “Malaria Pipeline Highlights – 2017 Update” drug pipelines has been added to’s offering. Malaria Pipeline Highligh...

Osteoarthritis Pipeline Highlights Update 2017 –

DUBLIN–(BUSINESS WIRE)–The “Osteoarthritis Pipeline Highlights – 2017 Update” drug pipelines has been added to’s offering. Osteoarthritis Pip...

An MS Drug Update

Cutting the risk for natalizumab-related PML, update on disability outcomes with ibudilast, and daclizumab pulled from the global market. Medscape Neurology

ARK Releases Technical Update -- Introducing API V2

LONS-LE-SAUNIER, France, Feb. 18, 2018/PRNewswire/ --  All-In-One Blockchain solution, ARK has begun the testing phase of their Core 2 update, starting with their Read more...

Huntington’s Disease Pipeline Highlights – 2017 Update –

DUBLIN–(BUSINESS WIRE)–The “Huntington’s Disease Pipeline Highlights – 2017 Update” drug pipelines has been added to’s offering. The la...

Drugs and Medications [0 Results]


PubMed Articles [437 Associated PubMed Articles listed on BioPortfolio]

The Dental Update Readers' Panel.

Noonan syndrome: an update on growth and development.

To provide an update on recent developments on Noonan syndrome with a special focus on endocrinology, bone, and metabolism aspects. The key issues still to be resolved and the future therapeutic persp...

An update of the evidence on the potential impact of periodontal therapy on diabetes outcomes.

To provide an update of the systematic review by Engebretson and Kocher J Clin Periodontol. 2013 Apr;40 Suppl 14:S153 on the effect of periodontal therapy on glycaemic control of people with diabetes.

30th Annual APRN Legislative Update: Improving access to healthcare one state at a time.

The Annual Legislative Update describes recent legislative changes to practice, reimbursement, and prescriptive authority that have the most impact on NPs and other advanced practice nurses across the...

An update on the reasons for placement and replacement of direct restorations.

The aim of this study was to review patterns of restoration placement and replacement. A previous study had been carried out in the late 1990s and this study sought to update the literature in this im...

Clinical Trials [77 Associated Clinical Trials listed on BioPortfolio]

European Organisation of Research and Treatment (EORTC) Quality of Life Questionnaire (QLQ) Breast Cancer Module Update

The purpose of this study is to update the EORTC QLQ Breast (BR)-23 Module. Since the development of BR-23 published 1996 the standard therapy of breast cancer has changed. New therapies b...

Support Annual Strain Update, Safey and Immnogenicity of an Inactivated, Adjuvanted Influenza Vaccine, Formulation 2007-2008, When Administered to Subjects 18-64 Years Affected by Chronic Diseases.

This phase II, open label, is designed as a seasonal study to support annual strain update evaluating the safety, clinical tolerability and immunogenicity of the 2007-2008 formulation of ...

Sub-study for the Validation and Calibration of Data Regarding Physical Activity, Anthropometry and Diet

This study was an update and amplification of exposure measurements of the EPIC-Potsdam Study, which started in 1994-1998.

A Prospective Double-Blind Study of Retrovir in Early HIV Infection

To evaluate the safety and tolerance of chronic administration of Retrovir (AZT) to adult patients with early manifestations of HIV disease. To assess the efficacy of AZT therapy in the tr...

A Study of Atezolizumab (Tecentriq®) in Ministry of Food and Drug Safety (MFDS)-Approved Indication(s)

This Phase 4, prospective, multicenter, non-interventional, regulatory post-marketing surveillance study will collect information on the the safety and effectiveness of atezolizumab under ...

Companies [46 Associated Companies listed on BioPortfolio]

update CRM Inc.

update CRM Inc. provides innovative and unique cloud-based customer relationship management (CRM) solutions to a growing number of small and large life sciences companies in the U...

Update AG


Update Pharma Inc.

Update Pharma Inc. is developing UPI-928, an agent developed in the 1980’s by Lederle Laboratories in 44 phase 1, 2 and 3 clinical trials, including 33 clinical trials at the...

The Hartford Income Shares Fund, Inc.

This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act, with respect to the fund’s future financial or b...


WHAT:2012 Annual Meeting featuring Gov. Robert Bentley, an update of the BioAlabama Five Year Strategic Plan and presentation of Biotechnology Resolution by Sen. Jabo Waggoner and...

More Information about "Update AG" on BioPortfolio

We have published hundreds of Update AG news stories on BioPortfolio along with dozens of Update AG Clinical Trials and PubMed Articles about Update AG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Update AG Companies in our database. You can also find out about relevant Update AG Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record